Shares of ReWalk Robotics Ltd. (NASDAQ:RWLK) rose 11.7% during trading on Friday . The company traded as high as $7.67 and last traded at $7.53, with a volume of 83,777 shares trading hands. The stock had previously closed at $6.74.

RWLK has been the subject of a number of recent analyst reports. Zacks Investment Research upgraded shares of ReWalk Robotics from a “hold” rating to a “buy” rating and set a $11.00 price objective for the company in a research report on Tuesday, May 10th. Jefferies Group restated a “buy” rating and issued a $16.00 price objective on shares of ReWalk Robotics in a research report on Sunday, May 8th.

The firm has a 50-day moving average price of $7.24 and a 200 day moving average price of $9.50. The company’s market capitalization is $91.55 million.

ReWalk Robotics (NASDAQ:RWLK) last issued its quarterly earnings data on Thursday, May 5th. The medical device company reported ($0.48) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.60) by $0.12. During the same quarter in the prior year, the business earned ($0.48) earnings per share. The business had revenue of $2.06 million for the quarter, compared to analyst estimates of $1.56 million. The firm’s quarterly revenue was up 224.6% compared to the same quarter last year. On average, equities research analysts predict that ReWalk Robotics Ltd. will post ($2.11) earnings per share for the current year.

In other news, Director Wayne Weisman sold 16,148 shares of ReWalk Robotics stock in a transaction dated Friday, May 20th. The shares were sold at an average price of $9.09, for a total transaction of $146,785.32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Scp Vitalife Partners Ii Lp sold 20,256 shares of ReWalk Robotics stock in a transaction dated Thursday, May 26th. The shares were sold at an average price of $8.69, for a total transaction of $176,024.64. The disclosure for this sale can be found here.

A hedge fund recently bought a new stake in ReWalk Robotics stock. EAM Investors LLC acquired a new position in shares of ReWalk Robotics Ltd. (NASDAQ:RWLK) during the fourth quarter, according to its most recent filing with the SEC. The firm acquired 93,333 shares of the medical device company’s stock, valued at approximately $1,351,000. EAM Investors LLC owned approximately 0.77% of ReWalk Robotics at the end of the most recent quarter.

ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk. The Company offers ReWalk, an exoskeleton that uses its tilt-sensor technology, and an on-board computer and motion sensors to drive motorized legs that power movement.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.